2023 Annual Symposium on Risks and Opportunities of AI in Pharmaceutical Medicine

The Symposium on Risks and Opportunities of AI in Pharmaceutical Medicine was an event jointly sponsored by Pfizer Inc., the Roux Institute at Northeastern University and the American Statistical Association (ASA).

This event served as a platform for distinguished statisticians, data scientists, regulators, and other professionals to address the challenges and opportunities of AI in pharmaceutical medicine; to foster collaboration among industry, academia, regulatory agencies, and professional associations; and to propose recommendations with policy implications for proper implementation of AI in promoting public health.

As a convener of researchers in the fields of AI, data science, biotechnology, computational medicine, and more, industry partners, academic faculty, and entrepreneurs, the Roux Institute at Northeastern University was uniquely positioned to host this event and connect the experts needed to tackle the challenges and opportunities presented.

The Roux Institute at Northeastern University is a center of activity for both the Observational Health Data Sciences and Informatics Center (OHDSI), which advances healthcare by fostering reproducible research through open science, and the Institute for Experiential Artificial Intelligence (EAI), which researches and develops human-centric AI solutions that leverage machine technology to extend human intelligence. ​

As a co-sponsor with Pfizer Inc. and the American Statistical Association, the Roux Institute at Northeastern University was pleased to host this symposium focused on Risks and Opportunities of AI in Pharmaceutical Medicine.